Variant enzymes

US2016177281A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016177281-A1
Application numberUS-201414909031-A
CountryUS
Kind codeA1
Filing dateJul 24, 2014
Priority dateJul 29, 2013
Publication dateJun 23, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed are glycosyl hydrolase enzyme variants, particularly variants of certain oxidoreductases of glycosyl hydrolase family 61. Nucleic acids encoding the glycosyl hydrolyase variants, compositions including the glycosyl hydrolase variants, methods of producing the variants, and methods of using the variants are also described.

First claim

Opening claim text (preview).

1 . (canceled) 2 . A variant of a parent glycosyl hydrolase 61 (GH61) enzyme, wherein said variant has cellulase augmenting activity, and has at least 80% sequence identity to SEQ ID NO:3, wherein said variant comprises at least one amino acid substitution at a position selected from the group consisting of: T287, W13, L288, P19, T20, P29, A37, L39, D47, A48, S68, T107, S121, G122, T127, S164, G166, Q167, A168, N216, I218, I219, V224, T289, Y291, S297, T303, R304, A306, P308, S312, T313, N315, Y317, Y318, N5, I7, V12, Q15, T21, F22, S26, P28, V32, G33, T35, A36, N41, Q50, N51, K58, N59, V80, P89, T108, G116, L120, G123, V132, S135, N147, A161, A181, S183, S185, Q189, G195, T196, H200, A201, T202, I208, P222, T223, S226, S231, G235, L290, G295, G296, G298, Y299, S300, G301, P302, P307, A309, T310, P316, A319, L322, I4, I9, N10, P23, Y24, E25, N27, D38, F43, V44, Y49, P52, I54, T61, N62, K64, V69, K70, A71, I90, V91, N96, N98, D100, T103, E110, V117, L119, D124, P125, G126, V141, D146, A149, I160, H163, A171, N173, P175, I180, S187, L188, S191, L194, D197, P204, V206, L207, N209, Y211, S213, P214, Y217, T230, V232, A233, G292, Q293, Q320, and N323, wherein the position of each amino acid substitution corresponds to SEQ ID N0:3. 3 . The variant of claim 2 , wherein said variant comprises one or more of: an amino acid substitution at position T287 selected from the group consisting of: H, A, F, G, S, and I; an amino acid substitution at position W13 selected from the group consisting of: G, L, N, R, T, V, F, Q, Y, A, E, I, K, and M; an amino acid substitution at position L288 selected from the group consisting of: E, F, G, I, K, M, N, R, S, T, A, C, D, V, and W; an amino acid substitution at position P19 selected from the group consisting of: F, M, E, H, Q, T, K, and W; an amino acid substitution at position T20 selected from the group consisting of: K, P, G, M, R, Y, A, and N; an amino acid substitution at position P29 selected from the group consisting of: C, E, F, K, T, Y D, G, M, R, and S; an amino acid substitution at position A37 selected from the group consisting of: D, S, E, L, W, F, K, and Q; an amino acid substitution at position L39 selected from the group consisting of: A, D, E, M, T, Y, F, I, N, P, Q, S, and V; an amino acid substitution at position D47 selected from the group consisting of: A, K, T, H, R, P, and W; an amino acid substitution at position A48 selected from the group consisting of: C, E, G, K, L, N, T, Y, Q, W, H, I, and S; an amino acid substitution at position S68 selected from the group consisting of: E, I, L, M, N, T, V, and Y; an amino acid substitution at position T107 selected from the group consisting of: A, D, E, K, M, R, S, and G; an amino acid substitution at position S121 selected from the group consisting of: E, F, N, T, C, L, V, D, G, K, M, and Y; an amino acid substitution at position G122 selected from the group consisting of: E, N, S, V, A, M, T, F, and L; an amino acid substitution at position T127 selected from the group consisting of: A, E, F, I, L, M, V, W, and Y; an amino acid substitution at position S164 selected from the group consisting of: A, D, E, G, K, L, M, Q, R, V, and Y; an amino acid substitution at position G166 selected from the group consisting of: A, D, E, F, H, K, M, N, Q, and S; an amino acid substitution at position Q167 selected from the group consisting of: E, A, D, F, G, K, L, N, R, V, and Y; an amino acid substitution at position A168 selected from the group consisting of: E, M, D, F, I, L, N, P, Q, R, T, and Y; an amino acid substitution at position N216 selected from the group consisting of: D, Q, T, K, and P; an amino acid substitution at position I218 selected from the group consisting of: T, A, D, E, K, M, N, P, S, and V; an amino acid substitution at position I219 selected from the group consisting of: M, A, D, L, N, P, and Q; an amino acid substitution at position V224 selected from the group consisting of: Q, I, A, E, N, P, S, and T; an amino acid substitution at position T289 selected from the group consisting of: A, D, K, L, M, R, and S; an amino acid substitution at position Y291 selected from the group consisting of: A, F, G, I, K, L, M, N, R, S, V, W, D, and E; an amino acid substitution at position S297 selected from the group consisting of: D, E, K, N, Q, R, and T; an amino acid substitution at position T303 selected from the group consisting of: K, M, P, R, S, V, and Y; an amino acid substitution at position R304 selected from the group consisting of: A, C, D, E, N, Q, T, and V; an amino acid substitution at position A306 selected from the group consisting of: E, F, G, I, K, L, M, Q, T, and Y; an amino acid substitution at position P308 selected from the group consisting of: A, G, H, I, K, L, Q, R, S, T, V, W, and Y; an amino acid substitution at position S312 selected from the group consisting of: Q, F, G, I, K, L, M, N, T, V, D, R, and Y; an amino acid substitution at position T313 selected from the group consisting of: S, D, G, L, P, V, E, F, I, K, M, and Y; an amino acid substitution at position N315 selected from the group consisting of: S, H, L, Q, R, V, Y, E, K, and M; an amino acid substitution at position Y317 selected from the group consisting of: Q, S, V, R, E, G, L, M, P, and T; a Y318T amino acid substitution; an amino acid substitution at position N5 selected from the group consisting of: A, D, G, and S; an amino acid substitution at position I7 selected from the group consisting of: L, M, and V; an amino acid substitution at position V12 selected from the group consisting of: M and T; an amino acid substitution at position Q15 selected from the group consisting of: H, K, and D; an amino acid substitution at position T21 selected from the group consisting of: I, K, M, and S; an amino acid substitution at position F22 selected from the group consisting of: K, L, and R; an amino acid substitution at position S26 selected from the group consisting of: M, P, and T; an amino acid substitution at position P28 selected from the group consisting of: M, S, and V; an amino acid substitution at position V32 selected from the group consisting of: A and P; an amino acid substitution at position G33 selected from the group consisting of: Q, A, and S; an amino acid substitution at position T35 selected from the group consisting of: A, D, E, K, N, and S; an amino acid substitution at position A36 selected from the group consisting of: T, I, N, S, and Y; an amino acid substitution at position N41 selected from the group consisting of: D, E, L, and M; an amino acid substitution at position Q50 selected from the group consisting of: A, T, Y, D, E, and K; an amino acid substitution at position N51 selected from the group consisting of: S, E, H, K, L, and T; an amino acid substitution at position K58 selected from the group consisting of: I, R, and V; an amino acid substitution at position N59 selected from the group consisting of: G, E, Q, and S; an amino acid substitution at position V80 selected from the group consisting of: A, E, L, and M; an amino acid substitution at position P89 selected from the group consisting of: T, S, V, and L; an amino acid substitution at position T108 selected from the group consisting of: A, Q, R, and S; an amino acid substitution at position G116 selected from the group consisting of: H, Q, and S; an amino acid substitution at position L120 selected from the group consisting of: V, T, I, and S; an amino acid substitution at position G123 selected from the group consisting of: E, Q, and R; an amino acid substitution at position V132 selected from the group consisting of: D, E, M, and R; an amino acid substitution at position S135 selected from the group consisting of: A, E, G, H, M, and N; an amino acid substitution at position N147 selected from the group consisting of: E, M, S, and T; an amino acid substitution at position A161 selected from the group consisting of: E, G, L, and S; an amino ac

Assignees

Inventors

Classifications

  • C12N9/2437Primary

    Cellulases (3.2.1.4; 3.2.1.74; 3.2.1.91; 3.2.1.150) · CPC title

  • acting on beta-1,4-glucosidic bonds · CPC title

  • produced by the action of a carbohydrase {(EC 3.2.x)}, e.g. by alpha-amylase {, e.g. by cellulase, hemicellulase} · CPC title

  • Miscellaneous (1.14.99) · CPC title

  • hydrolysing O- and S- glycosyl compounds (3.2.1) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016177281A1 cover?
Disclosed are glycosyl hydrolase enzyme variants, particularly variants of certain oxidoreductases of glycosyl hydrolase family 61. Nucleic acids encoding the glycosyl hydrolyase variants, compositions including the glycosyl hydrolase variants, methods of producing the variants, and methods of using the variants are also described.
Who is the assignee on this patent?
Danisco Us Inc
What technology area does this patent fall under?
Primary CPC classification C12N9/2437. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Jun 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).